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Implications for Rehabilitation 
• Peripheral arterial disease has a considerable impact on functional capacity 
and quality of life 
 
• Functional capacity and quality of life are improved in patients with peripheral 
arterial disease up to one year post-participation in supervised exercise 
 
• Improvements at one year are reduced from those noted immediately 
following an exercise programme 
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Abstract 
Purpose  Peripheral arterial disease (PAD) is a chronic, progressive disease with a 
significant cardiovascular and cerebrovascular risk burden and a considerable 
impact on functional capacity and quality of life (QoL).  Exercise programmes result 
in significant improvements in walking distances but long-term effects are uncertain. 
The aim of this study was to assess the one-year effects of participation in a 12-week 
supervised exercise programme for PAD patients. 
Methods  Patients were randomly allocated to a control (n=16) or an exercise (n=28) 
group.  Data regarding functional capacity (Walking Impairment Questionnaire WIQ), 
disease-specific QoL (Intermittent Claudication Questionnaire ICQ) and generic QoL 
(SF-36) were collected at baseline, 12 weeks and one year.    
Results   At 12 weeks, there was a trend towards improved QoL in both groups, 
greater in the exercise group (p=.066) and a trend towards improved functional 
capacity (WIQ Stair-climbing p=.093) in the exercise group.  At one year, 
improvements in the exercise group (although reduced from those recorded 
immediately following the exercise programme) were maintained from baseline.  
Scores in the control group reflected a continuing deterioration in functional capacity 
and QoL. 
Conclusions   Participation in a supervised exercise programme results in 
improvements in functional capacity and QoL at one year post-participation. 
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Introduction 
Peripheral arterial disease (PAD) is a manifestation of generalised atherosclerotic 
disease in which the arterial lumen becomes progressively narrowed by 
atherosclerotic plaques.  This gradual narrowing of the lumen results in reduced 
blood flow to the tissues causing pain on exercise, relieved by rest (intermittent 
claudication [IC]).  PAD has two significant consequences – a reduction in quality of 
life (QoL) and functional capacity due to peripheral symptoms and a significantly 
increased cardiovascular morbidity and mortality risk.  While local disease in the leg 
follows a relatively benign course, the major morbidity and mortality risk is from 
associated coronary and cerebrovascular disease [1].   
Although the risk factors for PAD are the same as those for coronary artery disease, 
individuals with PAD face considerable challenges to exercise due to their 
symptomatology [2 ].  Walking is associated with the onset of leg pain and frequent 
rest periods during walking are required to relieve the pain. 
Management of PAD aims to improve cardiovascular risk factors and to maintain or 
improve QoL by eliminating ischaemic symptoms and preventing progression to 
vascular occlusion.   Exercise interventions have resulted in significant increases in 
treadmill walking distances [ 3 ] but the effects of these increases on quality of life 
and functional capacity in the community setting are unclear [4 ]. In addition the long-
term benefits in this patient population are also uncertain [3].  The aim of this study 
was to evaluate the one-year effects of participation in a 12-week supervised 
exercise programme for patients with IC.     
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Methods   
Study design  
This was a randomised controlled trial.  Data was collected at baseline, 12 weeks 
and one year.  Ethical approval for the study was obtained from the Hospital Ethics 
Committee.  
Participants 
Participants with an ankle:brachial index (ABI) < 0.9 were identified from the Non-
Invasive Vascular Laboratory logbook and medical charts subsequently reviewed for 
inclusion/exclusion criteria.  Inclusion criteria were: Fontaine Stage II (intermittent 
claudication) diagnosed by history of leg pain on exercise relieved by rest, classified 
by presence /absence of pulse/s, site of pain, ABI < 0.9 at rest and/or decrease in 
ankle pressure by 15mmHg or more after exercise, stable disease for 3 months and 
residing within the geographical catchment area of the hospital.  Exclusion criteria 
were: Fontaine Stages I, III and IV; coexisting clinical condition which precluded 
participation in exercise programme including unstable cardiorespiratory disease, 
neurological/orthopaedic limitation to exercise, poorly controlled hypertension, active 
major medical problem including but not limited to cancer, renal/liver disease, 
dementia, poorly controlled diabetes mellitus; abdominal aortic aneurysm; 
myocardial infarction within the previous 6 months; acute onset or within the first 
months of onset of claudication and revascularisation procedure/surgery within the 
previous 6 months.   
Procedure 
Participants who met the inclusion criteria were contacted by phone or letter to invite 
them to participate in the study.  Following written informed consent, participants 
were referred for a symptom-limited cardiopulmonary exercise test. The test was 
conducted to determine the participant’s cardiac status, possible underlying coronary 
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artery disease and to outrule any contraindications to participation in an exercise 
programme. Results of the treadmill test were also used to set the initial training 
workload.  The exercise test was conducted under cardiology supervision.  On 
successful completion of the exercise test, participants were randomly allocated to a 
control or an exercise group.  Randomisation was conducted by computer-generated 
random sealed envelope method.  
 
The control group continued with usual care, i.e. ABI measurement, advice regarding 
exercise and smoking cessation and review at scheduled out-patient clinic 
appointments.  The exercise group participated in a twice-weekly supervised 
exercise programme for 12 weeks.  A 12-week exercise programme has been 
recommended as initial treatment for PAD patients [5, 6 ].  The exercise programme 
was based on the hospital cardiac rehabilitation programme. The total duration of the 
programme was one hour, including warm-up and cool down periods. Participants 
underwent a 10 minute warm-up consisting of gentle walking, stepping and stretching 
exercises (upper limb, lower limb and trunk). Participants then exercised for 30-40 
minutes using a range of exercise equipment – treadmill, stepper, elliptical trainer, 
recumbent cycle ergometer and upper/lower limb cycle ergometer.  Individualised 
exercise programmes were designed.  Participants were encouraged to exercise at 
an intensity of 70-80% of their exercise test maximum or 70-80% predicted heart rate 
maximum if the exercise test was terminated due to the onset of ischaemic leg pain 
before predicted heart rate maximum was achieved.  On the treadmill participants 
were encouraged to continue exercising until they were unable to continue due to leg 
pain (generally a maximum of 10 minutes).  Participants were then permitted to rest 
until the pain subsided and then were encouraged to recommence exercising. The 
Page 5 of 22
URL: http:/mc.manuscriptcentral.com/dandr  Email: davemuller@suffolk.ac.uk
Disability and Rehabilitation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
5 
 
exercise level was set at an intensity that produced moderate claudication pain within 
5 minutes. Exercise was progressed by increasing resistance and/or time.  
 
Measurements 
Baseline data obtained for all participants included demographic information, 
cardiovascular risk factors, current medications, claudication history and blood 
samples. 
 
Functional Capacity 
The Walking Impairment Questionnaire (WIQ) has been specifically developed and 
validated for participants with IC to measure community-based walking ability [ 7, 8 ] 
and to monitor the effectiveness of therapeutic interventions.  It has been validated 
against treadmill testing for objective assessment of functional walking ability and 
recommended as an alternative to treadmill testing for use in daily practice [9 ].  The 
questionnaire assesses participant-reported walking speed, distance, stair-climbing 
ability and limitations in walking ability.  The participant ranks his/her degree of 
difficulty walking specific distances on a 0-4 Likert scale where 0 represents inability 
to walk the distance and 4 represents no difficulty.  For walking speed the subject 
ranks the degree of difficulty walking slowly, at average speed, quickly or running or 
jogging.  In the stair-climbing component, participants rank their ability to walk up and 
down one, two or three flights of stairs respectively.  Scores are divided by the 
maximum possible score to obtain the percentage score with higher scores indicating 
greater functional walking ability. 
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Disease- specific quality of life  
The Intermittent Claudication Questionnaire (ICQ) has been validated for use in an 
IC population to identify small but important changes in quality of life [ 10 ].  It 
consists of 16 items providing a single health dimension score and has a brief 
completion time (average 3.7 minutes).  Each question has a 5 or 6 point adjectival 
response scale.  It is scored from 0-100 where 0 is the best possible and 100 the 
worst possible health state.  Total score is calculated using the coding and 
transformation scheme developed by the authors.  Higher scores indicate poorer 
QOL.  
 
Generic quality of life   
The Medical Outcomes Study Short- Form 36 (MOS-SF36) questionnaire with 36 
items in eight scales and two summary measures is the recommended health status 
or generic QoL measurement instrument in PAD [5 ] and is the most widely used 
[11].  The 36-item questionnaire assesses eight health dimensions - physical 
functioning (PF), social functioning (SF), role limitations due to physical problems 
(RP), role limitations due to emotional problems (RE), bodily pain (BP), mental health 
(MH), vitality (VT) and general health (GH).  Each dimension has a scoring scale 
from 0 (worst quality of life) to 100 (best quality of life).  Scores representing overall 
physical functioning and mental functioning are calculated from the individual scales 
and are presented as the physical component scale (PCS) and the mental 
component scale (MCS).  Higher scores indicate better health states. The standard 
(4-week) recall version was used. 
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Statistical Analysis 
All variables were examined for accuracy of data entry, missing values and presence 
of outliers.  All variables were tested for normality using the Kolmogorov-Smirnov 
goodness-of-fit test.  Group differences at baseline for demographic and clinical 
characteristics were assessed by Chi square tests for categorical variables and 
independent t-tests for numeric variables.  Group differences at baseline for 
functional capacity and disease-specific quality of life scores were assessed by non-
parametric methods, i.e. the Mann-Whitney test.  SF-36 scores were examined using 
parametric tests (independent t-tests).  Differences between groups at 12 weeks 
were examined with ANCOVA analysis using the general linear model to control for 
baseline scores. The post-trial variable was the predicted variable and the baseline 
values and study group were entered as co-variates.  
For analysis of variables at baseline, 12 weeks and one year, each primary and 
secondary outcome was independently analysed with repeated measures analysis of 
variance.  The analysis was conducted to examine the effects of participation in the 
exercise intervention at one year post-participation in relation to both baseline scores 
and those observed at 12 weeks.  Within each outcome a Bonferroni adjustment was 
used to protect for a Type I error rate.  Simple (main) effects for time and study group 
and the interaction effect of time and study group were the factors of interest.  Where 
a significant result was found, means were further examined by pairwise 
comparisons using repeated measures ANOVA to examine the main effects of time, 
group and identify any differences in changes over time between the groups.  
Statistical significance was set at p< 0.05.  Data were analysed using the Statistical 
Package for the Social Sciences (SPSS) for Windows Version 17.0 (SPSS Inc., 
Chicago, Ill. USA).  
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Results 
During the period November 2006 – June 2009, 548 patients with an ankle:brachial 
index (ABI) < 0.9 at rest and residing within the geographical catchment area of the 
Hospital were identified from the Non-Invasive Vascular Laboratory logbook.  
Following review of medical charts one hundred and fifty–six patients met the 
inclusion criteria. Of these, one hundred and three patients agreed to participate and 
were scheduled for exercise testing.  Results of exercise testing are indicated in 
figure 1.  Forty-four patients were subsequently randomised to a control and an 
exercise group. 
 
Insert figure 1 about here 
 
Both groups had similar baseline demographic and clinical profiles and none of the 
profile characteristics were found to differ statistically significantly between the two 
groups (table1) with the exception of systolic blood pressure which was significantly 
higher (p=.027) in the control group.  There wer  no differences in medication use 
between the groups. 
 
Insert table 1 about here  
 
       
Patients were deemed to have completed the exercise programme if they had 80% 
or greater attendance at scheduled exercise sessions (n=24). Twelve participants 
(exercise n=11; control n=1) withdrew prior to 12-week data collection (figure 1) and 
one participant was unavailable due to stent insertion.  Regarding patients who 
withdrew from the exercise programme (n=11), all had withdrawn by week 4, i.e. 
commencing participants either withdrew early or completed the overall programme. 
There were no significant differences in any demographic or clinical variables 
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between those who withdrew and those who completed the programme The final 
numbers available for analysis at twelve weeks were 31 (exercise n=17 and control 
n=14).  Partial data only was available for one participant in the control group as the 
self-administered questionnaires were not returned.  This participant subsequently 
withdrew from the one-year assessment.   The final numbers available for analysis at 
one year were 30 (exercise n=17 and control n=13).  Data from 12 participants in the 
control group were available for analysis across all three time points.   
Outcome measures are presented in table 2.  
 
Insert table 2 about here 
 
The exercise group had lower average WIQ scores, i.e. poorer functional capacity, 
than the control group at baseline.  At twelve weeks, increases were observed in all 
WIQ scores in the exercise group with the largest mean difference over time in the 
WIQ Distance score (increase of 14.29 points) and a trend towards improvement 
observed for the WIQ Stair-climbing (p=.093) score.  At one year there was a 
significant interaction effect between Time and Study Group for the WIQ Stair-
climbing score [F (2, 54) = 3.654, p= .032] and average WIQ scores remained higher 
than at baseline. In the control group average WIQ scores at one year were lower 
than at baseline for all WIQ categories.  
 
At baseline the exercise group had higher scores for the Intermittent Claudication 
Questionnaire (ICQ), reflecting a poorer level of disease-specific quality of life.  At 
twelve weeks, there was a trend towards improved quality of life in both groups, 
greater in the exercise group (p =.066).  At one year, there was a significant 
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difference in ICQ over Time [F (2, 54) =5.268, p=.008] with a substantial interaction 
effect between Time and Study Group [F (2, 54) = 3.003, p=.058] (figure 2).   
Insert figure 2 about here  
No significant differences between groups were demonstrated for any of the SF-36 
scores over the three time points. 
 
 
Discussion   
The aim of this study was to evaluate the one-year effects of participation in a 12-
week supervised exercise programme on functional capacity and quality of life for 
patients with intermittent claudication (IC).  Intermittent claudication has a 
considerable impact on functional capacity [ 12 ]  with a reluctance to walk due to leg 
pain.  Quality of life in PAD patients is influenced by functional capacity [13 ] and the 
Walking Impairment Questionnaire (WIQ) is the most accurate qualitative measure of 
functional capacity [14].  It has been reported that the Distance score is the most 
sensitive to change following supervised exercise [15]. The results of the current 
study substantiate this.  Statin use has been shown to improve walking distance and 
speed in patients with PAD [16, 17 ].  However, as there was only one change (one 
participant commenced on statin medication during the 12-week exercise period) to 
medications during the 12-week study period in either group, this was not thought to 
be a contributing factor in this study.  At one year increases in all Walking Impairment 
Questionnaire (WIQ) categories in the exercise group were demonstrated, indicating 
maintenance of benefits although there was a decrease in scores from those 
recorded immediately following completion of the exercise programme.  Decreases 
in all WIQ scores in the control group from baseline to one year were found, 
reflecting a continuing deterioration in functional capacity. To the researchers’ 
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knowledge, WIQ data at one year following a 12-week supervised exercise 
programme is not available for comparison although improvements in Distance and 
Speed scores have recently been reported following a one-year supervised exercise 
intervention in the community [18]. 
At twelve weeks improvements were noted in the Intermittent Claudication 
Questionnaire (ICQ) scores in both groups with differences across groups bordering 
on significance.  Similar changes have been reported in other studies [19, 20 ].   
Improvements in ICQ scores following supervised exercise were reported with no 
changes in SF-36 scores [20] or borderline significant increase in the Physical 
Functioning domain only [19] reflecting the increased sensitivity of the disease-
specific measure.  However, neither of these studies were randomised controlled 
trials.  In the current study, although there was some increase in ICQ scores (i.e. QoL 
deterioration) in the exercise group at one year, scores remained at a lower level 
than baseline (reflecting improved QoL) and maintenance of benefits.  In the control 
group ICQ scores were higher than baseline scores indicating a deterioration in QoL 
at one year.   
The absence of research on long-term outcomes (i.e. one year or more) of exercise 
training has been highlighted [21].   Although maintenance of improvements in 
exercise capacity and activity patterns at two years following discharge from cardiac 
rehabilitation (CR) have been reported [22 ], the demographic profile of CR 
participants is quite dissimilar to the PAD population, i.e. younger, fewer 
comorbidities and this may influence on-going exercise participation following a 
formal exercise programme.  Additional support may be required in the PAD patient 
population to promote longer-term exercise benefits. Of note in the current study is 
that participants were primarily concerned about the presence of leg pain rather than 
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more serious cardiovascular complications with an under-appreciation of the link with 
coronary artery and cerebrovascular disease. However, 50% of participants were 
current smokers with increased mean body mass index and waist circumference 
values evident in both groups suggesting that participation in a multidisciplinary 
rehabilitation programme, targeting these increased cardiovascular risk factors would 
be beneficial. 
This study had a number of limitations.  As it was not feasible to monitor the level of 
unsupervised exercise that may have been undertaken by either group outside the 
formal programme, it is possible that this may have been a confounding factor.   
Inclusion in the study may have raised awareness of the benefit of exercise and 
patients in the control group may have increased their level of independent exercise 
and physical activity.  Increased monitoring of blood pressure, weight and blood test 
results may have influenced lifestyle behavioural changes and this may have 
resulted in a more optimal outcome for the control group than for a “usual care” group 
under normal circumstances. It is also possible that the presence of comorbid 
conditions was a confounding factor, impacting on functional capacity and quality of 
life.   
 
Conclusion 
Although small, study numbers were similar to other studies.  Reviews of exercise 
therapy for intermittent claudication have concluded that average study numbers in 
this patient population range from 20-59 participants as most patients are elderly and 
co-morbidities are common [3, 4 ].  Results demonstrated that participation in a 
supervised exercise programme resulted in improvements in functional capacity and 
quality of life at one year.  These benefits, while decreased from those recorded 
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immediately following completion of the exercise programme, were maintained at 
one year post-participation.  Referral to an on-going maintenance programme may 
be required to effect longer-term exercise benefits.   
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Figure 1. Exercise testing outcomes and participant flow through the study 
Tested 
n = 71 
Did not attend 
 n = 32 
Scheduled for testing 
 n= 103 
Completed n= 48 Not completed 
n = 23 
Reasons for test termination 
Test suggestive of myocardial ischaemia n = 14 
Hypertension at rest n = 3 
Exaggerated hypertensive response n = 4 
Abnormal resting ECG n= 1 
Unable to perform treadmill test n = 1 
Intervention group 
n = 28 
Control group 
n = 16 
Randomised  
Withdrew prior to 
enrolment (n=4) 
Angioplasty (1) 
Domestic reason (1) 
Medical problem (1) 
Declined (1) 
Assessed   
(12 weeks) 
n = 14 
Assessed post intervention 
(12 weeks) 
 n= 17 
Withdrew having attended at 
least 1 exercise session (11) 
Work (3) 
Domestic reasons (3) 
Medical reasons (3) 
Progression of PAD (2) 
Withdrew (1)* 
Progression of 
PAD (1) 
 
Assessed post intervention 
(1 year) 
n = 17 
Assessed  
(1 year) 
n - 13 
Page 19 of 22
URL: http:/mc.manuscriptcentral.com/dandr  Email: davemuller@suffolk.ac.uk
Disability and Rehabilitation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
2 
 
Table 1.  Baseline demographic and clinical characteristics  
       
 Control Group  
(n = 16) 
mean (SD) 
Exercise Group  
(n = 28) 
mean (SD) 
p value 
Demographic    
Age (yrs)  67.1(7.5) 67.0 (8.6) .970 
Male (%) 75  67.9 .617 
Current smoker (%) 43.5 55.5 .632 
Diabetes (%) 81.25 67.85 .325 
PAD Duration (%)    
3-12 months 
13-36 months 
> 36 months 
18.8 
31.3 
50  
14.8 
25.9 
59.3 
.947 
Ankle/brachial index (ABI)    
ABI resting (R) 
ABI resting (L) 
ABI exercise (R)  
ABI exercise (L) 
.76 (.20) 
.70 (.20) 
.68 (.31) 
.52 (.23) 
.78 (.23) 
.74 (.19) 
.58 (.34) 
.60 (.60) 
.769 
.564 
.408 
.418 
Cardiovascular Risk 
Factors 
   
Triglycerides (mmol/L) 2.06 (2.48) 1.63 (.73) .396 
Total cholesterol (mmol/L) 4.25 (1.03) 4.37 (1.05) .730 
LDL cholesterol (mmol/L) 2.17 (.78) 2.33 (.77) .520 
HDL cholesterol (mmol/L) 1.22 (.20) 1.29 (.45) .563 
HbA1C (mmol/L) 6.01 (.92) 5.93 (.72) .760 
Hs CRP(mg/L)
a 
11.63 (23.93) 9.23 (19.09) .722 
Fasting blood glucose 
(mmol/L) 
6.05 (1.30) 6.02 (2.21) .964 
Plasma Fibrinogen (g/L) 4.02 (.81) 3.88 (.79) .590 
Waist circumference (cms) 102 (7.03) 102.56 (12.17) .869 
BMI (kg/m
2
)
 
 29.74 (2.76) 29.59 (4.73) .896 
Systolic blood pressure 
(mmHg) 
150.3 (21.6) 136.6 (17.2) .027 
Diastolic blood pressure 
(mmHg) 
75.2 (7.0) 72.6 (7.5) .276 
  a 
Exercise n=26 
LDL cholesterol, Low-density lipoprotein cholesterol; HDL cholesterol, High-density lipoprotein 
cholesterol; HbA1C, Glycosylated haemoglobin; HsCRP, High-sensitivity C-reactive protein; BMI, 
Body Mass Index
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Table 2. Quality of Life and Functional Capacity Measures 
Outcome Measures Control Group (n=12) 
Mean (SD) 
Exercise Group (n= 17) 
Mean (SD) 
 Baseline 12 
weeks 
One year Baseline 12 
weeks 
One 
year 
ICQ 33.83 
(18.04) 
30.36 
(14.98) 
38.54 
(24.26) 
34.11 
(19.81) 
24.37 
(17.94) 
27.94 
(19.83) 
WIQ       
Stair- climbing 64.24 
(38.62) 
48.61 
(33.35) 
54.86 
(36.23) 
45.88 
(32.59) 
54.43 
(33.72) 
51.22 
(31.52) 
Distance 44.23 
(29.59) 
40.17 
(32.77) 
38.47 
(27.70) 
31.25 
(22.12) 
45.54 
(28.92) 
38.85 
(30.69) 
Speed 39.04 
(24.39) 
41.49 
(28.63) 
33.42 
(18.99) 
37.33 
(26.96) 
45.01 
(24.87) 
40.15 
(22.14) 
SF-36       
Physical Functioning (PF) 37.74 
(9.70) 
38.46 
(9.04) 
36.51 
(10.04) 
36.11 
(7.68) 
39.88 
(9.16) 
39.33 
(10.73) 
Role Physical (RP) 38.28 
(11.83) 
40.12 
(10.84) 
39.92 
(11.46) 
43.17 
(10.99) 
44.32 
(9.71) 
43.17 
(10.54) 
Bodily Pain (BP)  43.76 
(11.66) 
41.52 
(9.75) 
39.97 
(9.15) 
44.94 
(9.65) 
45.24 
(9.76) 
46.06 
(9.28) 
General Health (GH) 43.64 
(10.58) 
44.16 
(8.64) 
42.76 
(10.93) 
44.92 
(9.81) 
44.10 
(9.58) 
41.63 
(7.52) 
PCS
 
38.81 
(11.06) 
38.19 
(9.84) 
37.53 
(10.30) 
38.79 
(9.14) 
40.77 
(8.45) 
40.75 
(9.61) 
Vitality (VT) 46.60 
(12.00) 
46.89 
(9.72) 
45.85 
(10.40) 
48.97 
(9.50) 
51.17 
(8.74) 
48.60 
(8.96) 
Social Functioning (SF) 46.85 
(13.92) 
49.12 
(9.14) 
43.67 
(13.45) 
47.85 
(11.24) 
49.79 
(10.87) 
43.38 
(14.83) 
Role Emotional (RE) 42.27 
(12.79) 
49.16 
(14.40) 
41.95 
(14.87) 
48.56 
(11.32) 
49.02 
(9.67) 
45.13 
(13.50) 
Mental Health (MH) 48.84 
(9.49) 
49.78 
(8.86) 
48.60 
(7.35) 
50.34 
(9.44) 
51.50 
(8.97) 
50.84 
(8.20) 
MCS
 
49.40 
(8.65) 
52.05 
(9.22) 
48.58 
(10.25) 
53.35 
(9.79) 
54.10 
(9.10) 
49.99 
(10.95) 
ICQ, Intermittent Claudication Questionnaire; WIQ, Walking Impairment Questionnaire; SF-36, 
Medical Outcomes Survey Short-Form 36; PCS, Physical Component Summary; MCS, Mental 
Component Summary 
  
Page 21 of 22
URL: http:/mc.manuscriptcentral.com/dandr  Email: davemuller@suffolk.ac.uk
Disability and Rehabilitation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
4 
 
 
 
 
 
Figure 2. Intermittent Claudication Questionnaire mean scores at Baseline, 12 weeks 
and One year 
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